Literature DB >> 25598534

Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis.

Margaret R Karagas1, Janet L Peacock2, Judy R Rees3, M Scot Zens4, Maria O Celaya3, Bruce L Riddle3.   

Abstract

A retrospective cohort analysis of survival after keratinocyte cancer (KC) was conducted using data from a large, population-based case-control study of KC in New Hampshire. The original study collected detailed information during personal interviews between 1993 and 2002 from individuals with squamous (SCC) and basal (BCC) cell carcinoma, and controls identified through the Department of Transportation, frequency-matched on age and sex. Participants without a history of non-skin cancer at enrolment were followed as a retrospective cohort to assess survival after either SCC or BCC, or a reference date for controls. Through 2009, cancers were identified from the New Hampshire State Cancer Registry and self-report; death information was obtained from state death certificate files and the National Death Index. There were significant differences in survival between those with SCC, BCC and controls (p = 0.040), with significantly greater risk of mortality after SCC compared to controls (adjusted hazard ratio [HR] 1.25; 95% confidence interval 1.01-1.54). Mortality after BCC was not significantly altered (HR 0.96; 95% CI 0.77-1.19). The excess mortality after SCC persisted after adjustment for numerous personal risk factors including time-varying non-skin cancer occurrence, age, sex and smoking. Survival from the date of the intervening cancer, however, did not vary (HR for SCC 0.98; 95% CI 0.70-1.38). Mortality also remained elevated when individuals with subsequent melanoma were excluded (HR for SCC 1.30; 95% CI 1.05-1.61). Increased mortality after SCC cannot be explained by the occurrence of intervening cancers, but may reflect a more general predisposition to life threatening illness that merits further investigation.
© 2015 UICC.

Entities:  

Keywords:  basal cell carcinoma; squamous cell carcinoma; survival

Mesh:

Year:  2015        PMID: 25598534      PMCID: PMC4478145          DOI: 10.1002/ijc.29436

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  45 in total

1.  The accuracy of death certificate completion in a suburban community.

Authors:  Bob Cambridge; Stephen J Cina
Journal:  Am J Forensic Med Pathol       Date:  2010-09       Impact factor: 0.921

2.  Non-melanoma skin cancer and ten-year all-cause mortality: a population-based cohort study.

Authors:  Annette Østergaard Jensen; Anna Lei Lamberg; Jacob Bonde Jacobsen; Anne Braae Olesen; Henrik Toft Sørensen
Journal:  Acta Derm Venereol       Date:  2010-07       Impact factor: 4.437

3.  Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women.

Authors:  Fatima Birch-Johansen; Allan Jensen; Lone Mortensen; Anne Braae Olesen; Susanne K Kjær
Journal:  Int J Cancer       Date:  2010-11-01       Impact factor: 7.396

4.  Risk of second cancers after the diagnosis of non-melanoma skin cancer in Korean patients.

Authors:  Mi Ryung Roh; Hyun Joon Shin; Soo Hyun Lee; Kee Yang Chung
Journal:  J Dermatol       Date:  2012-03-02       Impact factor: 4.005

5.  Incidence estimate of nonmelanoma skin cancer in the United States, 2006.

Authors:  Howard W Rogers; Martin A Weinstock; Ashlynne R Harris; Michael R Hinckley; Steven R Feldman; Alan B Fleischer; Brett M Coldiron
Journal:  Arch Dermatol       Date:  2010-03

6.  Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.

Authors:  Chrysalyne D Schmults; Pritesh S Karia; Joi B Carter; Jiali Han; Abrar A Qureshi
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

7.  Prior history of non-melanoma skin cancer is associated with increased mortality in patients with chronic lymphocytic leukemia.

Authors:  Jorge R Toro; Patrick W Blake; Magnus Björkholm; Sigurdur Y Kristinsson; Zhuoqiao Wang; Ola Landgren
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

8.  Characteristics associated with early and late melanoma metastases.

Authors:  Jeremy A Brauer; Cooper C Wriston; Andrea B Troxel; Rosalie Elenitsas; Daniel B Shin; Dupont Guerry; Michael E Ming
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

9.  Mortality in cancer patients with a history of cutaneous squamous cell carcinoma--a nationwide population-based cohort study.

Authors:  Sigrun Alba Johannesdottir; Timothy L Lash; Annette Østergaard Jensen; Dóra Körmendiné Farkas; Anne Braae Olesen
Journal:  BMC Cancer       Date:  2012-03-29       Impact factor: 4.430

10.  Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.

Authors:  Sarah N Robinson; Michael S Zens; Ann E Perry; Steven K Spencer; Eric J Duell; Margaret R Karagas
Journal:  J Invest Dermatol       Date:  2013-01-23       Impact factor: 8.551

View more
  15 in total

1.  Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study.

Authors:  Shohreh F Farzan; Yu Chen; Judy R Rees; M Scot Zens; Margaret R Karagas
Journal:  Toxicol Appl Pharmacol       Date:  2015-06-03       Impact factor: 4.219

Review 2.  Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis.

Authors:  Saverio Caini; Maria Sofia Cattaruzza; Benedetta Bendinelli; Giulio Tosti; Giovanna Masala; Patrizia Gnagnarella; Melania Assedi; Ignazio Stanganelli; Domenico Palli; Sara Gandini
Journal:  Eur J Nutr       Date:  2016-07-07       Impact factor: 5.614

Review 3.  All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  Mackenzie R Wehner; Wilmarie Cidre Serrano; Adi Nosrati; Patrick Michael Schoen; Mary-Margaret Chren; John Boscardin; Eleni Linos
Journal:  J Am Acad Dermatol       Date:  2017-11-13       Impact factor: 11.527

Review 4.  Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review.

Authors:  Virginia Barton; Kent Armeson; Shalaka Hampras; Laura K Ferris; Kala Visvanathan; Dana Rollison; Anthony J Alberg
Journal:  Arch Dermatol Res       Date:  2017-03-11       Impact factor: 3.017

Review 5.  Non-Melanoma Skin Cancers in the Older Patient.

Authors:  Ashley Albert; Miriam A Knoll; John A Conti; Ross I S Zbar
Journal:  Curr Oncol Rep       Date:  2019-07-29       Impact factor: 5.075

Review 6.  Keratinocyte Carcinomas: Current Concepts and Future Research Priorities.

Authors:  Priyadharsini Nagarajan; Maryam M Asgari; Adele C Green; Samantha M Guhan; Sarah T Arron; Charlotte M Proby; Dana E Rollison; Catherine A Harwood; Amanda Ewart Toland
Journal:  Clin Cancer Res       Date:  2018-12-06       Impact factor: 12.531

7.  Clinical and pathological features associated with high-risk, multiple, and recurrent basal cell carcinomas: a retrospective cohort analysis from the Levantine coast of the Mediterranean Sea.

Authors:  Boutros Soutou; Carine Massih; Ghassan Sleilaty; Viviane Trak-Smayra; Marwan Nasr; Josiane Helou; Nabil Hokayem; Fady Ferran; Fadi H Sleilati; Farid Stéphan; Maya Halabi-Tawil; Roland Tomb
Journal:  Arch Dermatol Res       Date:  2022-01-21       Impact factor: 3.017

8.  Coffee, tea, caffeine, and risk of nonmelanoma skin cancer in a Chinese population: The Singapore Chinese Health Study.

Authors:  Choon Chiat Oh; Aizhen Jin; Jian-Min Yuan; Woon-Puay Koh
Journal:  J Am Acad Dermatol       Date:  2019-02-05       Impact factor: 15.487

9.  Sex Differences in Health-related Quality of Life in Patients with Keratinocyte Carcinomas.

Authors:  Francesca Sampogna; Andrea Paradisi; Maria Luisa Iemboli; Luca Fania; Francesco Ricci; Monica Napolitano; Damiano Abeni
Journal:  Acta Derm Venereol       Date:  2021-04-27       Impact factor: 3.875

10.  Epidemiology of Keratinocyte Carcinoma.

Authors:  David M Perry; Virginia Barton; Anthony J Alberg
Journal:  Curr Dermatol Rep       Date:  2017-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.